This updated meta-analysis aimed to further quantify the risk of endometrial, ovarian, and breast cancer in patients with polycystic ovary syndrome (PCOS), thus providing updated and more reliable estimates.
Methods and Results
We identified relevant articles by searching electronic databases of PubMed, Embase, Web of Science, and Chinese Biological Medical Literature (CBM) published up to March 20, 2021. The pooled effect estimates and their 95% confidence intervals (CIs) were calculated using the random-effect model or the fixed-effect model. A total of 26 eligible studies were included. We found that PCOS was significantly associated with endometrial cancer (odds ratios [OR]: 3.66, 95%CI: 2.05–6.54, P < 0.001), but not with ovarian or breast cancer (OR: 1.23, 95%CI: 0.99–1.53, P = 0.059; OR: 0.94, 95%CI: 0.78–1.14, P = 0.551, respectively). However, in subgroups of high-quality studies, cohort studies, younger women (54 years or less or premenopausal), and studies with unadjusted body mass index (BMI), PCOS patients had a significantly higher risk of ovarian cancer.
Conclusion
These results indicated that PCOS is a significant risk factor for endometrial cancer independent of BMI, but not for breast cancer. PCOS may increase the risk of ovarian cancer in younger women.
GilbertEWTayCTHiamDS, et al.Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Clin Endocrinol (Oxf)2018; 89: 683–699.
3.
TeedeHDeeksAMoranL. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med2010; 8: 41.
4.
GottschauMKjaerSKJensenA, et al.Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study. Gynecol Oncol2015; 136: 99–103.
5.
YinWFalconerHYinL, et al.Association between polycystic ovary syndrome and cancer risk. JAMA Oncol2019; 5: 106–107.
6.
ChittendenBGFullertonGMaheshwariA,et al.Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online2009; 19: 398–405.
7.
HaoulaZSalmanMAtiomoW. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod2012; 27: 1327–1331.
8.
BarryJAAziziaMMHardimanPJ. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update2014; 20: 748–758.
9.
ShobeiriFJenabiE. The association between polycystic ovary syndrome and breast cancer: a meta-analysis. Obstet Gynecol Sci2016; 59: 367–372.
10.
BrownZALouwersYVFongSL, et al.The phenotype of polycystic ovary syndrome ameliorates with aging. Fertil Steril2011; 96: 1259–1265.
GreenlandS. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev1987; 9: 1–30.
13.
HigginsJPThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat Med2002; 21: 1539–1558.
14.
BorensteinMHedgesLVHigginsJP,et al.A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods2010; 1: 97–111.
15.
BeggCBMazumdarM. Operating characteristics of a rank correlation test for publication bias. Biometrics1994; 50: 1088–1101.
16.
EggerMDavey SmithGSchneiderM,et al.Bias in meta-analysis detected by a simple, graphical testBr Med J1997; 315: 629–634.
17.
EscobedoLGLeeNCPetersonHB,et al.Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol1991; 77: 124–128.
18.
SchildkrautJMSchwinglPJBastosE, et al.Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol1996; 88: 554–559.
19.
AndersonKESellersTAChenPL, et al.Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer1997; 79: 494–499.
20.
TalaminiRFranceschiSFaveroA, et al.Selected medical conditions and risk of breast cancer. Br J Cancer1997; 75: 1699–1703.
21.
NiwaKImaiAHashimotoM, et al.A case-control study of uterine endometrial cancer of pre- and post-menopausal women. Oncol Rep2000; 7: 89–93.
22.
WildSPierpointTJacobsH,et al.Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb)2000; 3: 101–105.
23.
IatrakisGZervoudisSSaviolakisA, et al.Women younger than 50 years with endometrial cancer. Eur J Gynaecol Oncol2006; 27: 399–400.
24.
OlsenCMGreenACNagleCM, et al.Epithelial ovarian cancer: testing the 'androgens hypothesis’. Endocr Relat Cancer2008; 15: 1061–1068.
25.
ZucchettoASerrainoDPoleselJ, et al.Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev2009; 18: 316–321.
26.
FearnleyEJMarquartLSpurdleAB, et al.Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. Cancer Causes Control2010; 21: 2303–2308.
27.
GhasemiNMortazavizadehMRGerdekoohiAK. Frequency of poly cystic ovary syndrome in patients with premenopausal breast cancer. Iran J Reprod Med2010; 8: 86–89.
28.
BodmerMBeckerCMeierC, et al.Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecol Oncol2011; 123: 200–204.
29.
KimJMersereauJEKhankariN, et al.Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case-control study. Cancer Causes Control2016; 27: 403–414.
30.
HarrisHRTitusLJCramerDW,et al.Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study. Int J Cancer2017; 140: 285–291.
31.
DingDCChenWWangJH,et al.Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: a population-based cohort study in Taiwan. Medicine (Baltimore2018; 97: e12608.
32.
HarrisHRBabicAWebbPM, et al.Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian cancer histotypes: evidence from the ovarian cancer association consortium. Cancer Epidemiol Biomarkers Prev2018; 27: 174–182.
33.
CenLWangL. [Clinical risk factors analysis of young women with early endometrial carcinoma]. [Article in Chinese]. Chinese Journal of Clinical Medicine2012; 19: 511–513.
34.
WengQLiYZhouJ. [An analysis on risk factors of premenopausal endometrial cancer]. Article in Chinese] Journal of Chinese Oncology2012; 18: 456–459.
35.
MaCShangHZhuX. [Clinical risk factors analysis of young women with early endometrial carcinoma]. [Article in Chinese]. Journal of Taishan Medical College2015; 36: 944–945.
36.
PalombaSPiltonenTTGiudiceLC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update2021; 27: 584–618.
37.
GiudiceLC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab2006; 20: 235–244.
38.
SpeertH. Carcinoma of the endometrium in young women. Surg Gynecol Obstet1949; 88: 332–336.
39.
MeczekalskiBPerez-RonceroGRLopez-BaenaMT, et al.The polycystic ovary syndrome and gynecological cancer risk. Gynecol Endocrinol2020; 36: 289–293.
40.
DimitrakakisCBondyC. Androgens and the breastBreast Cancer Res2009; 11: 212.
41.
CarvalhoMJSubtilSRodriguesA, et al.Controversial association between polycystic ovary syndrome and breast cancer. Eur J Obstet Gynecol Reprod Biol2019; 243: 125–132.
42.
BarberTMHansonPWeickertMO,et al.Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health2019; 13: 1179558119874042.
43.
TumminiaAVinciguerraFParisiM, et al.Adipose tissue, obesity and adiponectin: role in endocrine cancer risk. Int J Mol Sci2019; 20: 2863.
44.
HarrisHRTerryKL. Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review. Fertil Res Pract2016; 2: 14.
45.
GammonMDThompsonWD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol1991; 134: 818–824.
46.
BaronJAWeiderpassENewcombPA, et al.Metabolic disorders and breast cancer risk (United States). Cancer Causes Control2001; 12: 875–880.
47.
PillayOCTe FongLFCrowJC, et al.The association between polycystic ovaries and endometrial cancer. Hum Reprod2006; 21: 924–929.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
